Cargando…
An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease.
Autores principales: | Cooper, E. H., Forbes, M. A., Taylor, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971573/ https://www.ncbi.nlm.nih.gov/pubmed/2257202 |
Ejemplares similares
-
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.
por: Kawa, S., et al.
Publicado: (1991) -
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
por: Hasegawa, Shinichiro, et al.
Publicado: (2023) -
An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
por: Cooper, E. H., et al.
Publicado: (1989) -
Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease
por: Storck, Lena J., et al.
Publicado: (2019) -
Serum hyaluronic acid levels in cancer.
por: Cooper, E. H., et al.
Publicado: (1988)